Biology subjects

Zhong, Y.

Publications and source records attributed to Zhong, Y..

5 recordsLinked to original sources

bioRxiv2018

Optical Sectioning of Live Mammal with Near-Infrared Light Sheet

Deep-tissue three-dimensional optical imaging of live mammals in vivo with high spatiotemporal resolution in non-invasive manners has been challenging due to light scattering. Here, we developed near-infrared (NIR) light sheet microscopy (LSM) with optical excitation and emission wavelengths up to ~ 1320 nm and ~ 1700 nm respectively, far into the NIR-II (1000-1700 nm) region for 3D optical sectioning through live tissues. Suppressed scattering of both excitation and emission photons allowed one-photon optical sectioning at ~ 2 mm depth in highly scattering brain tissues. NIR-II LSM enabled non-invasive in vivo imaging of live mice, revealing never-before-seen dynamic processes such as highly abnormal tumor microcirculation, and 3D molecular imaging of an important immune checkpoint protein, programmed-death ligand 1 (PD-L1) receptors at the single cell scale in tumors. In vivo two-color near-infrared light sheet sectioning enabled simultaneous volumetric imaging of tumor vasculatures and PD-L1 proteins in live mammals.

bioengineering↗

bioRxiv2018

MSCypher: an integrated database searching and machine learning workflow for multiplexed proteomics.

Improvements in shotgun proteomics approaches are hampered by increases in multiplexed (chimeric) spectra, as improvements in peak capacity, sensitivity or dynamic range all increase the number of co-eluting peptides. This results in diminishing returns using traditional search algorithms, as co-fragmented spectra are known to decrease identification rates. Here we describe MSCypher, a freely available software suite that enables an extensible workflow including a hybrid supervised machine learned strategy that dynamically adjusts to individual datasets. This results in improved identification rates and quantification of low-abundant peptides and proteins. In addition, the integration of peptide de novo sequencing and database searching enables an unbiased view of variants and high-intensity unassigned peptide spectral matches.\n\nHighlightsO_LIOpen-source end-to-end label-free proteomics workflow\nC_LIO_LIIntegrated database searching and machine learning\nC_LIO_LICustomisable and extensible workflow including de novo sequencing\nC_LIO_LIOptimised for multiplexed spectra, challenging proteomics datasets and peptidomics applications\nC_LI

bioinformatics↗

bioRxiv2018

The Biological Evaluation of Fusidic Acid and Its Hydrogenation Derivative as Antimicrobial and Anti-inflammatory Agents

Fusidic acid (WU-FA-00) is the only commercially available antimicrobial from the fusidane family that has a narrow spectrum of activity against Gram-positive bacteria. Herein, the hydrogenation derivative (WU-FA-01) of fusidic acid was prepared, and both compounds were examined against a panel of six bacterial strains. In addition, their anti-inflammation properties were evaluated using a 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse ear edema model. The results of the antimicrobial assay revealed that both WU-FA-00 and WU-FA-01 displayed a high level of antimicrobial activity against Gram-positive strains. Moreover, killing kinetic studies were performed, and the results were in accordance with the MIC and MBC results. We also demonstrated that the topical application of WU-FA-00 and WU-FA-01 effectively decreased TPA-induced ear edema in a dose-dependent manner. This inhibitory effect was associated with the inhibition of TPA-induced up-regulation of pro-inflammation cytokines IL-1{beta}, TNF- and COX-2. WU-FA-01 significantly suppressed the expression levels of p65, I{kappa}B-, and p-I{kappa}B- in the TPA-induced mouse ear model. Overall, our results showed that WU-FA-00 and WU-FA-01 not only had effective antimicrobial activities in vitro, especially to the Gram-positive bacteria, but also possessed strong anti-inflammatory effects in vivo. These results provide a scientific basis for developing fusidic acid derivatives as antimicrobial and anti-inflammatory agents.

pharmacology and toxicology↗

bioRxiv2017

Coupling effect of morphology and mechanical properties contributes to the tribological behaviors of snake scales

It is known that the tribological behaviors of snake skins are contributed by the synergistic action of multiple factors, such as surface morphology and mechanical properties, which has inspired fabrication of scale-like surface textures in recent years. However, the coupling effect and mechanism remain to be elucidated. In this work, the morphology and mechanical properties of the scales from different body sections (leading body half, middle trunk and trailing body half) and positions (dorsal, lateral and ventral) of Boa constrictor and Eryx tataricus have been characterized and compared to investigate the corresponding effects on the tribological behaviors and to probe the possible coupling mechanism. The morphological characterizations of scanning electron microscopy and atomic force microscopy have revealed significant differences between the two species with the roughness of scales from Boa constrictor being larger in general. The mechanical properties measured by nanoindentation have corroboratively demonstrated substantial differences in terms of elastic modulus and hardness. Meanwhile, tribological characterizations of scales in different body positions from the two species also exhibit evident anisotropy. Interestingly, the ventral scales manifest higher friction coefficients but lower surface roughness, together with relatively larger elastic modulus and hardness. A \"double-crossed\" hypothesis has been proposed to explain the observed coupling effect of the morphology and mechanical properties on friction, which may afford valuable insights for the design of materials with desirable tribological performance.

animal behavior and cognition↗

bioRxiv2017

Mapping The Malaria Parasite Drug-Able Genome Using In Vitro Evolution And Chemogenomics

Chemogenetic characterization through in vitro evolution combined with whole genome analysis is a powerful tool to discover novel antimalarial drug targets and identify drug resistance genes. Our comprehensive genome analysis of 262 Plasmodium falciparum parasites treated with 37 diverse compounds reveals how the parasite evolves to evade the action of small molecule growth inhibitors. This detailed data set revealed 159 gene amplifications and 148 nonsynonymous changes in 83 genes which developed during resistance acquisition. Using a new algorithm, we show that gene amplifications contribute to 1/3 of drug resistance acquisition events. In addition to confirming known multidrug resistance mechanisms, we discovered novel multidrug resistance genes. Furthermore, we identified promising new drug target-inhibitor pairs to advance the malaria elimination campaign, including: thymidylate synthase and a benzoquinazolinone, farnesyltransferase and a pyrimidinedione, and a dipeptidylpeptidase and an arylurea. This deep exploration of the P. falciparum resistome and drug-able genome will guide future drug discovery and structural biology efforts, while also advancing our understanding of resistance mechanisms of the deadliest malaria parasite.\n\nOne Sentence SummaryWhole genome sequencing reveals how Plasmodium falciparum evolves resistance to diverse compounds and identifies new antimalarial drug targets.

genomics↗